Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Biomedical Microdevices|April 9, 2011
Biomedical soft contact-lens sensor for in situ ocular biomonitoring of tear contentsMingXing Chu, Takayuki Shirai, Daishi Takahashi, et al.
Biomaterials Science|March 17, 2025
Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrierTakaaki Nakatsukasa, Daisuke Muraoka, Situo Deng, et al.
Molecular Pharmaceutics|March 26, 2026
Cationic Nanogel Coated Norovirus VLP Nasal Vaccine Induces Neutralizing Mucosal IgA and Serum IgG AntibodiesYoshikazu Yuki, Shiho Kurokawa, Tomoyuki Yamanoue, et al.
Frontiers in Immunology|July 25, 2022
Induction of Mucosal IgA-Mediated Protective Immunity Against Nontypeable Haemophilus influenzae Infection by a Cationic Nanogel-Based P6 Nasal VaccineRika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, et al.
Molecular Pharmaceutics|February 23, 2021
Characterization and Specification of a Trivalent Protein-Based Pneumococcal Vaccine Formulation Using an Adjuvant-Free Nanogel Nasal Delivery SystemYoshikazu Yuki, Yohei Uchida, Shin-Ichi Sawada, et al.
Vaccine|June 29, 2023
Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primatesYoshikazu Yuki, Norihiro Harada, Shin-Ichi Sawada, et al.
International Journal of Molecular Sciences|May 14, 2022
Theranostic Agent Combining Fullerene Nanocrystals and Gold Nanoparticles for Photoacoustic Imaging and Photothermal TherapyRiku Kawasaki, Kosuke Kondo, Risako Miura, et al.
Science Translational Medicine|November 12, 2025
Cationic nanogel-based nasal therapeutic HPV vaccine prevents the development of cervical cancerRika Nakahashi-Ouchida, Hiromi Mori, Yoshikazu Yuki, et al.
Nature Materials|June 22, 2010
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccinesTomonori Nochi, Yoshikazu Yuki, Haruko Takahashi, et al.
NPJ Vaccines|September 18, 2024
Low-frequency CD8+ T cells induced by SIGN-R1+ macrophage-targeted vaccine confer SARS-CoV-2 clearance in miceDaisuke Muraoka, Meng Ling Moi, Osamu Muto, et al.
Pageof 9